Skip to content
ClinCalc Pro
Menu
cardiology

T-MACS Troponin-Only Manchester ACS Decision Aid

Single time-point decision aid combining arrival high-sensitivity troponin T (Roche) with 6 clinical features to estimate the probability of acute coronary syndrome (Body 2017). Very low risk (< 2 %) supports rule-out at presentation; ≥ 95 % rules in.

Roche Elecsys high-sensitivity troponin T only — the model is assay-specific (not for troponin I)

Score interpretation

Very low risk — ACS ruled out (< 2 %) 0–1.99

T-MACS probability of ACS below 2 %.

→ Consider discharge from the ED with safety-netting and follow-up as indicated (Body 2017).

Low risk (2 to < 5 %) 2–4.99

T-MACS probability of ACS 2 to < 5 %.

→ Serial troponin testing in a low-dependency area.

Moderate risk (5 to < 95 %) 5–94.99

T-MACS probability of ACS 5 to < 95 %.

→ Further investigation including serial troponin; admission or observation per local pathway.

High risk — ACS ruled in (≥ 95 %) 95–100

T-MACS probability of ACS 95 % or more.

→ Treat as acute coronary syndrome per the local pathway; urgent cardiology review.

Interpretation bands for the T-MACS. Apply clinical judgement and local guidance.

References

Related

Curated clinical cross-links plus same-class fallbacks.

Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.